Log In
Print this Print this

illumigene Pertussis

  Manage Alerts
Collapse Summary General Information
Company Meridian Bioscience Inc.
Descriptionin vitro molecular diagnostic using isothermal DNA amplification technology to detect Bordetella pertussis in nasopharyngeal swab samples for use on the Meridian's illumigene platform
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect Bordetella pertussis infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today